FDA inspection

R. Doyle Stulting, MD: FDA inspection ending Aug 18, 2023

FDA inspection 1215156 · Voluntary Action Indicated (VAI) · Atlanta, GA

Key facts

Inspection ID 1215156
Firm R. Doyle Stulting, MD
FEI number 3010543346
Address 800 Mount Vernon Hwy NE Ste 130
City Atlanta
State GA
ZIP 30328
Country United States
Fiscal year 2023
Inspection end date Aug 18, 2023
Classification Voluntary Action Indicated (VAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections